NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1...
Stay updated with breaking news from Ganesh Kishore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1...
Provivi Team Successfully introducing insect pheromones to control damaging pests, the increased funding will strengthen the capacity for a global roll-out SANTA MONICA, CA, UNITED STATES, December 22, 2020 /EINPresswire.com/ -- Provivi, Inc. ("Provivi"), an emerging crop protection company using pheromones to protect large acreage row crops from major damaging insects, is pleased to inform the completion of a $45.5M financing round. Vivo Capital, a Palo Alto based investment fund, led the round. Returning shareholders, including Kairos Ventures, Temasek, Pontifax AgTech...